To explore the diagnostic utility of TUG1, they compared TUG1 expression levels in different stages of disease in MM patients, alone or together with other diagnostic biomarkers such as albumin and β2-microglobulin. The gene discussed is TUG1; the disease is Miyoshi myopathy.